BR122012015772A2 - - Google Patents
Info
- Publication number
- BR122012015772A2 BR122012015772A2 BR122012015772A BR122012015772A BR122012015772A2 BR 122012015772 A2 BR122012015772 A2 BR 122012015772A2 BR 122012015772 A BR122012015772 A BR 122012015772A BR 122012015772 A BR122012015772 A BR 122012015772A BR 122012015772 A2 BR122012015772 A2 BR 122012015772A2
- Authority
- BR
- Brazil
Links
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24182500P | 2000-10-19 | 2000-10-19 | |
US60/241,825 | 2000-10-19 | ||
BRPI0114704 | 2001-10-15 | ||
PCT/IB2001/001940 WO2002032900A2 (en) | 2000-10-19 | 2001-10-15 | Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
Publications (4)
Publication Number | Publication Date |
---|---|
BR122012015772A2 true BR122012015772A2 (no) | 2004-02-25 |
BR122012015772A8 BR122012015772A8 (pt) | 2017-10-03 |
BR122012015772B1 BR122012015772B1 (pt) | 2018-05-02 |
BR122012015772B8 BR122012015772B8 (pt) | 2021-05-25 |
Family
ID=62103641
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR122012015772A BR122012015772B8 (pt) | 2000-10-19 | 2001-10-15 | compostos de imidazol fundidos a atila ou heteroarila |
Country Status (1)
Country | Link |
---|---|
BR (1) | BR122012015772B8 (no) |
-
2001
- 2001-10-15 BR BR122012015772A patent/BR122012015772B8/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
BR122012015772B8 (pt) | 2021-05-25 |
BR122012015772A8 (pt) | 2017-10-03 |
BR122012015772B1 (pt) | 2018-05-02 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B25G | Requested change of headquarter approved |
Owner name: RAQUALIA PHARMA INC. (JP) |
|
B25A | Requested transfer of rights approved |
Owner name: RAQUALIA PHARMA INC. (JP) |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B25K | Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: republication |
Owner name: ASKAT INC. (JP) |
|
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] | ||
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 15/10/2001 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
B21A | Patent or certificate of addition expired [chapter 21.1 patent gazette] |
Free format text: PATENTE EXTINTA EM 15/10/2021 |